Weight-loss drugs like Ozempic and Wegovy are reshaping healthcare — and potentially the economy.
Dr Zac Turner explains to Sean Aylmer how GLP-1 drugs work, what we’re still learning about their long-term effects, why the next generation matters, and how these medications may go far beyond weight loss.

Fed govt sues 3M for $2b; Ferrari EV launch a flop; Rinehart richest Australian
16:09

Q+A: How Australia’s richest people really make - and keep - their money
09:54

Afternoon Report | ASX tumbles on Middle East hostilities
05:14